TEMOZOLOMIDE (Rising Pharmaceuticals, Inc.)
Welcome to the PulseAid listing for the TEMOZOLOMIDE drug offered from Rising Pharmaceuticals, Inc.. This Alkylating Activity [MoA],Alkylating Drug [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Rising Pharmaceuticals, Inc. |
NON-PROPRIETARY NAME: | temozolomide |
SUBSTANCE NAME: | TEMOZOLOMIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Alkylating Activity [MoA],Alkylating Drug [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | CAPSULE |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2017-03-17 |
END MARKETING DATE: | 0000-00-00 |
TEMOZOLOMIDE HUMAN PRESCRIPTION DRUG Details:
Item Description | TEMOZOLOMIDE from Rising Pharmaceuticals, Inc. |
LABELER NAME: | Rising Pharmaceuticals, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 5(mg/1) |
START MARKETING DATE: | 2017-03-17 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 64980-333_1c22f9d0-ae27-4e69-8b33-e634071128e8 |
PRODUCT NDC: | 64980-333 |
APPLICATION NUMBER: | ANDA206309 |
Other TEMOZOLOMIDE Pharmaceutical Manufacturers / Labelers: